Φορτώνει......
BCMA-targeted immunotherapy for multiple myeloma
B cell maturation antigen (BCMA) is a novel treatment target for multiple myeloma (MM) due to its highly selective expression in malignant plasma cells (PCs). Multiple BCMA-targeted therapeutics, including antibody-drug conjugates (ADC), chimeric antigen receptor (CAR)-T cells, and bispecific T cell...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Hematol Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7499842/ https://ncbi.nlm.nih.gov/pubmed/32943087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-00962-7 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|